Clinical Trials Directory

Trials / Completed

CompletedNCT05561621

Prediction of Non-motor Symptoms in Fully Ambulatory MS Patients Using Vocal Biomarkers

Status
Completed
Phase
Study type
Observational
Enrollment
70 (actual)
Sponsor
Insel Gruppe AG, University Hospital Bern · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

The investigator will set up a study evaluating vocal biomarkers in people with MS in order to identify persons with non-motor symptoms: depression, cognitive deterioration, and fatigue. Up to now, to the best of the investigator's knowledge, there is no study reporting the use of vocal biomarkers to predict these three non-motor symptoms in people with MS.

Conditions

Interventions

TypeNameDescription
OTHERVoice analysisVoice analysis

Timeline

Start date
2022-07-15
Primary completion
2022-12-20
Completion
2022-12-20
First posted
2022-09-30
Last updated
2023-06-15

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT05561621. Inclusion in this directory is not an endorsement.

Prediction of Non-motor Symptoms in Fully Ambulatory MS Patients Using Vocal Biomarkers (NCT05561621) · Clinical Trials Directory